| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Linezolid Impurity 42 |
|
725676-93-7 |
詳細(xì)
|
| Rosuvastatin Impurity 12 |
|
894787-93-0 |
詳細(xì)
|
| Sodium 2-((2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl)acetate |
|
136983-81-8 |
詳細(xì)
|
| Linezolid Impurity 44 |
|
183805-10-9 |
詳細(xì)
|
| p-[N-(p-Fluorophenyl)formimidoyl]phenol |
|
3382-63-6 |
詳細(xì)
|
| Febuxostat Impurity 23 |
|
2073891-59-3 |
詳細(xì)
|
| Tetrabutylammonium periodate |
|
65201-77-6 |
詳細(xì)
|
| Pendimethalin |
|
40487-42-1 |
詳細(xì)
|
| Cefazolin Impurity D |
|
32510-61-5 |
詳細(xì)
|
| endo-BCN-PEG4-NHS ester |
|
1807501-86-5 |
詳細(xì)
|
| Celecoxib EP Impurity B |
|
331943-04-5 |
詳細(xì)
|
| Resiquimod-[d5] |
|
2252319-44-9 |
詳細(xì)
|
| Celecoxib EP Impurity A |
|
170570-01-1 |
詳細(xì)
|
| Rifaximin EP Impurity E |
|
13553-79-2 |
詳細(xì)
|
| PF-04457845 |
|
1020315-31-4 |
詳細(xì)
|
| Proteinase K |
|
39450-01-6 |
詳細(xì)
|
| GYY-4137 Morpholine salt |
|
106740-09-4 |
詳細(xì)
|
| 6-Ethynyl-4,4-Dimethyl Thiochroman |
|
118292-06-1 |
詳細(xì)
|
| N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide |
|
1255529-24-8 |
詳細(xì)
|
| Cefazolin EP Impurity G |
|
1172998-53-6 |
詳細(xì)
|
| Atorvastatin USP Related Compound C |
|
693793-53-2 |
詳細(xì)
|
| 1-methylpyridin-1-ium-2-carboxamide iodide |
|
3861-69-6 |
詳細(xì)
|
| Terazosin EP Impurity E |
|
102839-00-9 |
詳細(xì)
|
| 1-methylpyridin-1-ium-2-carboxamide chloride |
|
21032-31-5 |
詳細(xì)
|
| 6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine hydrochloride |
|
70843-11-7 |
詳細(xì)
|
| Dapoxetine Impurity 1 |
|
94305-25-6 |
詳細(xì)
|
| 3-(4-(3-hydroxy-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one |
|
2242008-36-0 |
詳細(xì)
|
| Nifuratel Impurity 6 |
|
25517-72-0 |
詳細(xì)
|
| (R)-Terazosin |
|
109351-34-0 |
詳細(xì)
|
| Nifuratel Impurity 4 |
|
41359-15-3 |
詳細(xì)
|
| Terbutaline Impurity 6 hydrobromide |
|
28924-20-1 |
詳細(xì)
|
| Dapoxetine Impurity 2 |
|
2242008-37-1 |
詳細(xì)
|
| Dapoxetine Impurity 8 |
|
2245197-07-1 |
詳細(xì)
|
| Palbociclib Impurity 10 |
|
2206135-30-8 |
詳細(xì)
|
| Palbociclib Impurity 2 |
|
2204863-06-7 |
詳細(xì)
|
| Palbociclib Impurity 022 |
|
1779124-68-3 |
詳細(xì)
|
| Palbociclib Impurity 025 |
|
2174002-16-3 |
詳細(xì)
|
| Palbociclib Impurity F |
|
1023594-49-1 |
詳細(xì)
|
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
|
1941177-45-2 |
詳細(xì)
|
| Valdecoxib Impurity I |
|
1373038-59-5 |
詳細(xì)
|
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide |
|
198471-06-6 |
詳細(xì)
|
| Valdecoxib Impurity B |
|
1373038-60-8 |
詳細(xì)
|
| Palbociclib Impurity 030 |
|
1211541-02-4 |
詳細(xì)
|
| Parecoxib Impurity 1 |
|
1708094-99-8 |
詳細(xì)
|
| methyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate |
|
1160293-25-3 |
詳細(xì)
|
| Palbociclib Impurity 029 |
|
1566082-34-5 |
詳細(xì)
|
| Lisinopril Impurity F |
|
1132650-67-9 |
詳細(xì)
|
| Terazosin EP Impurity O |
|
547730-06-3 |
詳細(xì)
|
| 1-Piperazinyl[(2R)-tetrahydro-2-furanyl]methanone |
|
412334-56-6 |
詳細(xì)
|
| Dapoxetine Impurity 2 hydrochloride |
|
2242008-38-2 |
詳細(xì)
|
| Terbutaline Impurity 22 |
|
1226543-90-3 |
詳細(xì)
|
| Esmolol Impurity 1 |
|
81147-94-6 |
詳細(xì)
|
| 3-(4-hydroxynaphthalen-1-yl)-1-phenylpropan-1-one |
|
126113-24-4 |
詳細(xì)
|
| N-Tert-Butyldibenzylamine |
|
30923-82-1 |
詳細(xì)
|
| Nifuratel Impurity 2 |
|
1445990-09-9 |
詳細(xì)
|
| Dapoxetine Impurity 24 |
|
908291-72-5 |
詳細(xì)
|
| tert-butyl 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carboxylate |
|
1260939-66-9 |
詳細(xì)
|
| Dabigatran Impurity 20 |
|
1408238-39-0 |
詳細(xì)
|
| Paroxetine Mesylate |
|
217797-14-3 |
詳細(xì)
|
| (2S)-Isopropyl 2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
|
1256490-52-4 |
詳細(xì)
|
| Valdecoxib Impurity E |
|
1373038-63-1 |
詳細(xì)
|
| Hydroxy Ivabradine |
|
1235547-07-5 |
詳細(xì)
|
| 3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole |
|
219986-64-8 |
詳細(xì)
|
| Parecoxib Impurity 24 |
|
198470-82-5 |
詳細(xì)
|
| Dacarbazine |
|
4342-03-4 |
詳細(xì)
|
| 19-Hydroxy-10-deacetyl baccatin-III |
|
154083-99-5 |
詳細(xì)
|
| Fomesafen |
|
72178-02-0 |
詳細(xì)
|
| Deoxyandrographolide |
|
79233-15-1 |
詳細(xì)
|
| Mogrol |
|
88930-15-8 |
詳細(xì)
|
| Nα,Nα-Bis-Fmoc-L-cystine bis(tert-butyl ester) |
|
139592-37-3 |
詳細(xì)
|
| Ethyl 2-bromothiophene-3-carboxylate |
|
632325-50-9 |
詳細(xì)
|
| Posaconazole Diastereoisomer Related Compound 2 |
|
166583-12-6 |
詳細(xì)
|
| 15(S)-Latanoprost |
|
145773-22-4 |
詳細(xì)
|
| Pantoprazole EP Impurity E |
|
2115779-15-0 |
詳細(xì)
|
| Triethylene Glycol Mono(2-propynyl) Ether |
|
208827-90-1 |
詳細(xì)
|
| Chrysin-7-O-glucuronide |
|
35775-49-6 |
詳細(xì)
|
| Monodes(N-carboxymethyl)valine Daclatasvir |
|
1007884-60-7 |
詳細(xì)
|
| Dapagliflozin USP Related Compound A |
|
1807632-95-6 |
詳細(xì)
|
| Ingenol-5,20-acetonide |
|
77573-43-4 |
詳細(xì)
|
| MCP110 |
|
521310-51-0 |
詳細(xì)
|
| Heptakis(6-deoxy-6-thio)-beta-cyclodextrin |
|
160661-60-9 |
詳細(xì)
|
| Cy5-NHS ester |
|
146368-14-1 |
詳細(xì)
|
| Semax |
|
80714-61-0 |
詳細(xì)
|
| Rosuvastatin EP Impurity G |
|
1242184-42-4 |
詳細(xì)
|
| Polyadenosinic acid potassium salt |
|
26763-19-9 |
詳細(xì)
|
| Apelin-36 (rat, mouse) |
|
230299-95-3 |
詳細(xì)
|
| Erlotinib Impurity 8 |
|
328528-74-1 |
詳細(xì)
|
| HIV-1 TAT Protein Peptide |
|
191936-91-1 |
詳細(xì)
|
| [Pyr1]-Apelin-13 |
|
217082-60-5 |
詳細(xì)
|
| β-Amyloid (1-40) |
|
131438-79-4 |
詳細(xì)
|
| ACTH (1-39), rat |
|
77465-10-2 |
詳細(xì)
|
| RADA 16 |
|
289042-25-7 |
詳細(xì)
|
| (3R,5R)-Rosuvastatin Calcium |
|
1422515-55-6 |
詳細(xì)
|
| Ethyl 5-bromothieno[3,2-b]thiophene-6-carboxylate |
|
2055722-78-4 |
詳細(xì)
|
| DOTA-NOC |
|
619300-53-7 |
詳細(xì)
|
| 2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethan-1-one sulfate |
|
882066-15-1 |
詳細(xì)
|
| Terazosin Related Compound A |
|
60548-08-5 |
詳細(xì)
|
| Mirabegron impurity 002 |
|
81259-56-5 |
詳細(xì)
|
| Mirabegron impurity 003 |
|
1018983-85-1 |
詳細(xì)
|
| Leucosceptoside A |
|
83529-62-8 |
詳細(xì)
|